Matthew J. Giefer

Matthew J. Giefer

Auto-generated profile, based on publicly available information

Matthew J. Giefer

Seattle Children's Hospital, Seattle, WA, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
SKSoma Kumar
Soma Kumar
KOKeith Ooi
Keith Ooi
SWSteven Werlin
Steven Werlin
MAMaisam Abu-El-Haija
Maisam Abu-El-Haija
BBBradley Barth
Bradley Barth
AUAliye Uc
Aliye Uc
Acute recurrent pancreatitis (ARP) and chronic pancreatitis (CP) are poorly understood conditions of childhood.1 Single-center studies estimate that 9% to 35% of children with acute pancreatitis (AP) have recurrent episodes,2-5 and the incidence of CP is approximately 0.5 per 100 000 persons per year in young adults.6,7

1 April 2015 in The Journal of Pediatrics
Verified
Journal Article
Closed access
SSSarah Jane Schwarzenberg
Sarah Jane Schwarzenberg
MBMelena Bellin
Melena Bellin
SHSohail Z. Husain
Sohail Z. Husain
MAMonika Ahuja
Monika Ahuja
BBBradley Barth
Bradley Barth
AUAliye Uc
Aliye Uc

1 April 2016 in Nutrition
Verified
Journal Article
Closed access
COChinonyelum Obih
Chinonyelum Obih
GWGhassan Wahbeh
Ghassan Wahbeh
DLDale Lee
Dale Lee
KBKim Braly
Kim Braly
MGMatthew Giefer
Matthew Giefer
DSDavid Suskind
David Suskind

1 February 2018 in Journal of Clinical Gastroenterology
Verified
Journal Article
Open access
PDF file
DSDavid Suskind
David Suskind
SCStanley A. Cohen
Stanley A. Cohen
MBMitchell J. Brittnacher
Mitchell J. Brittnacher
GWGhassan Wahbeh
Ghassan Wahbeh
DLDale Lee
Dale Lee
SMSamuel I. Miller
Samuel I. Miller
Goal: To determine the effect of the specific carbohydrate diet (SCD) on active inflammatory bowel disease (IBD). Background: IBD is a chronic idiopathic inflammatory intestinal disorder associated with fecal dysbiosis. Diet is a potential therapeutic option for IBD based on the hypothesis that changing the fecal dysbiosis could decrease intestinal inflammation. Study: Pediatric patients with mild to moderate IBD defined by pediatric Crohn’s disease activity index (PCDAI 10-45) or pediatric ulcerative colitis activity index (PUCAI 10-65) were enrolled into a prospective study of the SCD. Patients started SCD with follow-up evaluations at 2, 4, 8, and 12 weeks. PCDAI/PUCAI, laboratory studies were assessed. Results: Twelve patients, ages 10 to 17 years, were enrolled. Mean PCDAI decreased from 28.1±8.8 to 4.6±10.3 at 12 weeks. Mean PUCAI decreased from 28.3±23.1 to 6.7±11.6 at 12 weeks. Dietary therapy was ineffective for 2 patients while 2 individuals were unable to maintain the diet. Mean C-reactive protein decreased from 24.1±22.3 to 7.1±0.4 mg/L at 12 weeks in Seattle Cohort (nL<8.0 mg/L) and decreased from 20.7±10.9 to 4.8±4.5 mg/L at 12 weeks in Atlanta Cohort (nL<4.9 mg/L). Stool microbiome analysis showed a distinctive dysbiosis for each individual in most prediet microbiomes with significant changes in microbial composition after dietary change. Conclusions: SCD therapy in IBD is associated with clinical and laboratory improvements as well as concomitant changes in the fecal microbiome. Further prospective studies are required to fully assess the safety and efficacy of dietary therapy in patients with IBD.

1 September 2012 in Journal of Clinical Gastroenterology
Verified
Journal Article
Closed access
HBHarrison X. Bai
Harrison X. Bai
MGMatthew Giefer
Matthew Giefer
MPMohini Patel
Mohini Patel
AOAbrahim I. Orabi
Abrahim I. Orabi
SHSohail Z. Husain
Sohail Z. Husain
The association between primary hyperparathyroidism (PHPT) and acute or chronic pancreatitis is controversial. For this reason, we conducted a review of the literature over the past 30 years to explore the relationship between these 2 disorders. Ten retrospective studies each with >50 patients diagnosed with PHPT were identified. With the notable exception of 2 studies, the rate of pancreatitis among patients with PHPT was higher than that reported in general among hospitalized patients without PHPT. A higher serum calcium level may contribute to pancreatitis in these cases, along with additional genetic or environmental insults. Hypercalcemia may predispose the pancreatic acinar cell to abnormal, sustained calcium levels, lead to premature pancreatic protease activation, and pancreatitis. Although there was only short-term follow-up, most reports cited that definitive treatment of PHPT by parathyroidectomy led to the resolution of pancreatitis attacks. The published cohorts of patients with PHPT and pancreatitis are subject to bias, because serum calcium screening was not universally performed among all control nonpancreatitis patients to evaluate for PHPT. However, the pooled clinical and experimental data suggest an association between PHPT and pancreatitis and implicate hypercalcemia. For clinicians, it is important to recognize pancreatitis in patients with PHPT and, conversely, to consider PHPT by checking serum calcium levels in patients, who present with an unexplained pancreatitis.

12 February 2015 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
MGMatthew J. Giefer
Matthew J. Giefer
RKRichard A. Kozarek
Richard A. Kozarek